Format

Send to

Choose Destination
Yale J Biol Med. 2010 Mar;83(1):1-9.

Platelet-rich plasma: support for its use in wound healing.

Author information

1
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520-8089, USA.

Abstract

Previous topical growth factor studies have shown that recombinant human platelet-derived growth factor-BB isomer (rhPDGF-BB) is an efficacious treatment of chronic diabetic foot ulceration. A newer treatment, autologous platelet-rich plasma (PRP), represents a greater similarity to the natural healing process as a composite of multiple growth factors, is safe due to its autologous nature, and is produced as needed from patient blood. A review of the literature shows few studies performed with scientific rigor, although the safety of PRP appears to be validated. As the use of PRP increases, additional studies may establish PRP as an efficacious treatment modality and guide future treatment of chronic diabetic foot ulceration.

KEYWORDS:

autologous; diabetic foot; platelet-rich plasma; therapy; ulcer; wound healing; wounds

PMID:
20351977
PMCID:
PMC2844688
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center